Defining the risk of developing Grade 2 proctitis following 125I prostate brachytherapy using a rectal dose-volume histogram analysis

International Journal of Radiation Oncology Biology Physics

Volumn 50, Issue 2, 2001, Pages 335-341

  Snyder, Kurt M ^a   Stock, Richard G ^a   Hong, Suzanne M ^a   Lo, Yeh Chi ^a   Stone, Nelson N ^a  

^a MOUNT SINAI SCHOOL OF MEDICINE   (United States)

Author keywords

Proctitis; Prostate brachytherapy; Rectal dosimetry

Indexed keywords

IMPLANTS (SURGICAL); PATIENT MONITORING; RADIATION;

BRACHYTHERAPY;

DISEASES;

IODINE 125;

ADULT; AGED; ARTICLE; BRACHYTHERAPY; COMPUTER ASSISTED TOMOGRAPHY; CONTROLLED STUDY; DIABETES MELLITUS; DISEASE SEVERITY; DOSE RESPONSE; DOSIMETRY; DRUG IMPLANTATION; HISTOGRAM; HUMAN; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; PROCTITIS; PROSTATE CANCER; RADIATION DOSE; RISK ASSESSMENT; TECHNIQUE; TUMOR VOLUME; ULTRASOUND;

AGED; ANALYSIS OF VARIANCE; BRACHYTHERAPY; DOSE-RESPONSE RELATIONSHIP, RADIATION; HUMANS; IODINE RADIOISOTOPES; MALE; MIDDLE AGED; PRACTICE GUIDELINES; PROCTITIS; PROSTATIC NEOPLASMS; RADIATION INJURIES; RADIOMETRY; RECTUM;

EID: 0035371057     PISSN: 03603016     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0360-3016(01)01442-0     Document Type: Article

References (21)

1. Stock R.G., Stone N.N., Tabert A., et al. A dose-response study for I-125 prostate implants. Int J Radiat Oncol Biol Phys. 41:1998;101-108.
2. 125I prostate implantation. Int J Radiat Oncol Biol Phys. 37:1997;559-563.
3. Blasko J.C., Ragde H., Luse R.W., et al. Should brachytherapy be considered a therapeutic option in localized prostate cancer? Urol Clin North Am. 23:1996;633-650.
4. Wallner K., Roy J., Harrison L. Tumor control and morbidity following transperineal iodine 125 implantation for stage T1/T2 prostatic carcinoma. J Clin Oncol. 14:1996;449-453.
5. Stock R.G., Stone N.N., DeWyngaert J.K. Prostate specific antigen findings and biopsy results following interactive ultrasound guided transperineal brachytherapy for early stage prostate carcinoma. Cancer. 77:1996;2386-2392.
6. Stock R.G., Stone N.N., Wesson M.F., et al. A modified technique allowing interactive ultrasound-guided three-dimensional transperineal prostate implantation. Int J Radiat Oncol Biol Phys. 32:1995;219-225.
7. Prestidge B.R., Bice W.S., Kiefer E.J., et al. Timing of computed tomography-based postimplant assessment following permanent transperineal prostate brachytherapy. Int J Radiat Oncol Biol Phys. 40:1998;1111-1115.
8. Nag S., Bice W., DeWyngaert K., et al. The American Brachytherapy Society recommendations for permanent prostate brachytherapy postimplant dosimetric analysis. Int J Radiat Oncol Biol Phys. 46:2000;221-230.
9. Nath R., Anderson L.L., Luxton G., et al. Dosimetry of interstitial brachytherapy sources Recommendations of the AAPM Radiation Therapy Committee Task Group No. 43 . Med Phys. 22:1995;209-234.
10. Winchester D.P., Cox J.D. Standards for breast conservation treatment. Ca Center J Clin. 2:1992;134-162.
11. Kaplan E.L., Meier P. Non parametric estimation from incomplete observations. J Am Stat Assoc. 53:1958;457-481.
12. Cox DR, Oakes D. Analysis of survival data. Chapman and Hall. 1984.
13. Mantel N. Evaluation of survival data and two new rank order statistics arising in its consideration. Cancer Chemother Rep. 50:1966;163-170.
14. Hanks G.E., Schultheiss T.E., Hanlon A.L., et al. Optimization of conformal radiation treatment of prostate cancer Report of a dose escalation study . Int J Radiat Oncol Biol Phys. 37:1997;543-550.
15. Zelefsky M.J., Cowen D.M., Fuks Z., et al. Long term tolerance of high dose three-dimensional conformal radiotherapy in patients with localized prostate cancer. Cancer. 85:1999;2460-2468.
16. Skwarchuk M.W., Jackson A., Zelefsky M.J., et al. Late rectal toxicity after conformal radiotherapy of prostate cancer (I) multivariate analysis and dose-response . Int J Radiat Oncol Biol Phys. 47:2000;103-113.
17. Boersma L.J., van den Brink M., Bruce A.M., et al. Estimation of the incidence of late bladder and rectum complications after high-dose (70-78 Gy) conformal radiotherapy for prostate cancer, using dose-volume histograms. Int J Radiat Oncol Biol Phys. 41:1998;83-92.
18. Hartford A.C., Niemierko A., Adams J.A., et al. Conformal irradiation of the prostate Estimating long-term rectal bleeding risk using dose-volume histograms . Int J Radiat Oncol Biol Phys. 36:1996;721-730.
19. Wallner K., Roy J., Harrison L. Dosimetry guidelines to minimize urethral and rectal morbidity following transperineal I-125 prostate brachytherapy. Int J Radiat Oncol Biol Phys. 32:1995;465-471.
20. Merrick G.S., Butler W.M., Dorsey A.T., et al. Rectal dosimetric analysis following prostate brachytherapy. Int J Radiat Oncol Biol Phys. 43:1999;1021-1027.
21. Stock R.G., Stone N.N., Lo Y.C. Intraoperative dosimetric representation of the real-time ultrasound-guided prostate implant. Techniques in Urology. 6:2000;95-98.